Search For "drugs controller general of india"
COVID-19: India's first intranasal vaccine by Bharat Biotech gets DCGI app
Updated : 3 years, 6 months ago IST
New Delhi [India], September 6 (ANI): The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India (DCGI) for the Intranasal Covid-19 vaccine.
Read More
DCGI chief Venugopal Somani's tenure extended by 3 months
Updated : 3 years, 7 months ago IST
New Delhi [India], August 17 (ANI): The tenure of Dr V G Somani as the Drugs Controller General of India (DCGI) has been extended by three months, according to an order issued by the Union Health Ministry.
Read More
DCGI approves India's first qHPV vaccine to treat cervical cancer
Updated : 3 years, 8 months ago IST
New Delhi [India], July 12 (ANI): India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer gets Drugs Controller General of India (DCGI) approval for market authorisation. This vaccine will be manufactured by the Serum Institute of India (SII).
Read More
SII's Covovax gets DCGI emergency use nod for children between 7-12 years
Updated : 3 years, 8 months ago IST
New Delhi [India], June 28 (ANI): The Drugs Controller General of India (DCGI) has given restricted emergency use authorisation (EUA) to Pune-based Serum Institute of India's COVID-19 vaccine 'Covovax' for children aged 7 to 12 years, sources told ANI.
Read More
DCGI gives emergency use authorisation to India's first mRNA COVID-19 vacc
Updated : 3 years, 8 months ago IST
New Delhi [India], June 28 (ANI): The Drugs Controller General of India (DCGI) has approved two doses of Pune-based Gennova Biopharmaceuticals' mRNA COVID-19 vaccine for restricted use in emergency situations for beneficiaries aged above 18 years age group.
Read More
Bharat Biotech's COVID-19 nasal vaccine phase III trials completed
Updated : 3 years, 9 months ago IST
Paris [France], June 19 (ANI): Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local time) said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India (DCG
Read More
Bharat Biotech seeks DCGI's permission to conduct Covaxin booster trials i
Updated : 3 years, 10 months ago IST
New Delhi [India], May 4 (ANI): Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct trials of Covaxin as COVID-19 vaccine booster dose in the 2-18 age group, sources said.
Read More
NTAGI to review data of COVID-19 vaccines for children aged 5-12 years: So
Updated : 3 years, 10 months ago IST
New Delhi [India], May 2 (ANI): The COVID-19 working group of the National Technical Advisory Group on Immunisation (NTAGI) will review the data of COVID-19 vaccines for the children aged 5 to 12 years on May 4, said sources on Monday.
Read More
SEC seeks more data from Serum Institute over COVID vaccine Covovax for 7-
Updated : 3 years, 10 months ago IST
New Delhi [India], April 30 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee on Friday sought more data from Pune based Serum Institute of India (SII) on the Covovax vaccine for the age group of 7-12 years.
Read More
Paediatricians welcome COVID vaccines for kids, say parents mustn't hesita
Updated : 3 years, 10 months ago IST
New Delhi [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years.
Read More
DCGI approves COVID-19 vaccine Covaxin for children aged 6-12
Updated : 3 years, 10 months ago IST
Hyderabad (Telangana) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years.
Read More
Corbevax COVID-19 vaccine gets DCGI's nod for children aged 5-12
Updated : 3 years, 10 months ago IST
Hyderabad (Telangana) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) granted emergency use authorisation to Biological E's COVID-19 vaccine Corbevax for those aged 5 to 12 years, informed the pharmaceutical company on Tuesday.
Read More